Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-26

Clinical Trial Update: Testosterone Replacement in Non-alcoholic Steatohepatitis (TEREPINS) [Phase 2]

View source ↗

Summary

Phase 2 trial TERPINS evaluating testosterone replacement for nonalcoholic steatohepatitis in men with hypogonadism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TESTOSTERONE (testosterone)

Snippet

Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust | Conditions: Nonalcoholic Steatohepatitis, Hypogonadism | Phase 2 | Status: COMPLETED